{"doi":null,"coreId":"12436","oai":"oai:wrap.warwick.ac.uk:34573","identifiers":["oai:wrap.warwick.ac.uk:34573",null],"title":"Regulation of vascular endothelial growth factor bioactivity in patients with acute lung injury","authors":["Perkins, Gavin D.","Roberts, Jonathan","McAuley, Daniel F.","Armstrong, L.","Millar, Ann","Smith, F. Gao","Thickett, David R."],"enrichments":{"references":[],"documentType":{"type":1}},"contributors":[],"datePublished":"2005","abstract":"Background: Reduced bioactive vascular endothelial growth factor (VEGF) has been demonstrated in\\ud\nseveral inflammatory lung conditions including the acute respiratory distress syndrome (ARDS). sVEGFR-1,\\ud\na soluble form of VEGF-1 receptor, is a potent natural inhibitor of VEGF. We hypothesised that sVEGFR-1\\ud\nplays an important role in the regulation of the bioactivity of VEGF within the lung in patients with ARDS.\\ud\nMethods: Forty one patients with ARDS, 12 at risk of developing ARDS, and 16 normal controls were\\ud\nstudied. Bioactive VEGF, total VEGF, and sVEGFR-1 were measured by ELISA in plasma and\\ud\nbronchoalveolar lavage (BAL) fluid. Reverse transcriptase polymerase chain reaction for sVEGFR-1 was\\ud\nperformed on BAL cells.\\ud\nResults: sVEGFR-1 was detectable in the BAL fluid of 48% (20\/41) of patients with early ARDS (1.4\u2013\\ud\n54.8 ng\/ml epithelial lining fluid (ELF)) compared with 8% (1\/12) at risk patients (p = 0.017) and none of\\ud\nthe normal controls (p = 0.002). By day 4 sVEGFR-1 was detectable in only 2\/18 ARDS patients\\ud\n(p = 0.008). Patients with detectable sVEGFR-1 had lower ELF median (IQR) levels of bioactive VEGF than\\ud\nthose without detectable sVEGFR-1 (1415.2 (474.9\u20133192) pg\/ml v 4761 (1349\u20137596.6) pg\/ml, median\\ud\ndifference 3346 pg\/ml (95% CI 305.1 to 14711.9), p = 0.016), but there was no difference in total VEGF\\ud\nlevels. BAL cells expressed mRNA for sVEGFR-1 and produced sVEGFR-1 protein which increased\\ud\nfollowing incubation with tumour necrosis factor a.\\ud\nConclusion: This study shows for the first time the presence of sVEGFR-1 in the BAL fluid of patients with\\ud\nARDS. This may explain the presence of reduced bioactive VEGF in patients early in the course of ARDS","downloadUrl":"","fullTextIdentifier":null,"pdfHashValue":null,"publisher":"BMJ Group","rawRecordXml":"<record><header><identifier>\n    \n    \n      oai:wrap.warwick.ac.uk:34573<\/identifier><datestamp>\n      2017-12-22T15:31:33Z<\/datestamp><setSpec>\n      7375626A656374733D51:5150<\/setSpec><setSpec>\n      74797065733D61727469636C65<\/setSpec><setSpec>\n      636F6C6C656374696F6E3D77726170<\/setSpec><\/header><metadata><rioxx xmlns=\"http:\/\/www.rioxx.net\/schema\/v2.0\/rioxx\/\" xmlns:ali=\"http:\/\/ali.niso.org\/2014\/ali\/1.0\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:dcterms=\"http:\/\/purl.org\/dc\/terms\/\" xmlns:rioxxterms=\"http:\/\/docs.rioxx.net\/schema\/v2.0\/rioxxterms\/\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.rioxx.net\/schema\/v2.0\/rioxx\/ http:\/\/www.rioxx.net\/schema\/v2.0\/rioxx\/rioxx.xsd\" ><ali:free_to_read>\n    \n      <\/ali:free_to_read><dc:description>Background: Reduced bioactive vascular endothelial growth factor (VEGF) has been demonstrated in\\ud\nseveral inflammatory lung conditions including the acute respiratory distress syndrome (ARDS). sVEGFR-1,\\ud\na soluble form of VEGF-1 receptor, is a potent natural inhibitor of VEGF. We hypothesised that sVEGFR-1\\ud\nplays an important role in the regulation of the bioactivity of VEGF within the lung in patients with ARDS.\\ud\nMethods: Forty one patients with ARDS, 12 at risk of developing ARDS, and 16 normal controls were\\ud\nstudied. Bioactive VEGF, total VEGF, and sVEGFR-1 were measured by ELISA in plasma and\\ud\nbronchoalveolar lavage (BAL) fluid. Reverse transcriptase polymerase chain reaction for sVEGFR-1 was\\ud\nperformed on BAL cells.\\ud\nResults: sVEGFR-1 was detectable in the BAL fluid of 48% (20\/41) of patients with early ARDS (1.4\u2013\\ud\n54.8 ng\/ml epithelial lining fluid (ELF)) compared with 8% (1\/12) at risk patients (p = 0.017) and none of\\ud\nthe normal controls (p = 0.002). By day 4 sVEGFR-1 was detectable in only 2\/18 ARDS patients\\ud\n(p = 0.008). Patients with detectable sVEGFR-1 had lower ELF median (IQR) levels of bioactive VEGF than\\ud\nthose without detectable sVEGFR-1 (1415.2 (474.9\u20133192) pg\/ml v 4761 (1349\u20137596.6) pg\/ml, median\\ud\ndifference 3346 pg\/ml (95% CI 305.1 to 14711.9), p = 0.016), but there was no difference in total VEGF\\ud\nlevels. BAL cells expressed mRNA for sVEGFR-1 and produced sVEGFR-1 protein which increased\\ud\nfollowing incubation with tumour necrosis factor a.\\ud\nConclusion: This study shows for the first time the presence of sVEGFR-1 in the BAL fluid of patients with\\ud\nARDS. This may explain the presence of reduced bioactive VEGF in patients early in the course of ARDS.<\/dc:description><dc:format>application\/pdf<\/dc:format><dc:identifier>http:\/\/wrap.warwick.ac.uk\/34573\/1\/WRAP_Perkins_Regulation_vascular.pdf<\/dc:identifier><dc:language>en<\/dc:language><dc:publisher>BMJ Group<\/dc:publisher><dc:source>0040-6376<\/dc:source><dc:subject>QP<\/dc:subject><dc:title>Regulation of vascular endothelial growth factor bioactivity in patients with acute lung injury<\/dc:title><rioxxterms:author>Perkins, Gavin D.<\/rioxxterms:author><rioxxterms:author>Roberts, Jonathan<\/rioxxterms:author><rioxxterms:author>McAuley, Daniel F.<\/rioxxterms:author><rioxxterms:author>Armstrong, L.<\/rioxxterms:author><rioxxterms:author>Millar, Ann<\/rioxxterms:author><rioxxterms:author>Smith, F. Gao<\/rioxxterms:author><rioxxterms:author>Thickett, David R.<\/rioxxterms:author><rioxxterms:publication_date>2005<\/rioxxterms:publication_date><rioxxterms:type>Journal Article\/Review<\/rioxxterms:type><rioxxterms:version>NA<\/rioxxterms:version><rioxxterms:version_of_record>http:\/\/dx.doi.org\/10.1136\/thx.2004.027912<\/rioxxterms:version_of_record><\/rioxx><\/metadata><\/record>","journals":null,"language":{"code":"en","id":9,"name":"English"},"relations":[],"year":2005,"topics":["QP"],"subject":["QP"],"fullText":""}